EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H24O11 |
| Net Charge | 0 |
| Average Mass | 452.412 |
| Monoisotopic Mass | 452.13186 |
| SMILES | O=C(/C=C/C1(O)C=CC(O)CC1=O)OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O |
| InChI | InChI=1S/C21H24O11/c22-11-1-3-13(4-2-11)31-20-19(28)18(27)17(26)14(32-20)10-30-16(25)6-8-21(29)7-5-12(23)9-15(21)24/h1-8,12,14,17-20,22-23,26-29H,9-10H2/b8-6+/t12?,14-,17-,18+,19-,20-,21?/m1/s1 |
| InChIKey | MJKRDLMPYUENAA-OANOARFOSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Grevillea (ncbitaxon:83716) | |||
| twig (BTO:0001411) | PubMed (21155593) | Combined methanolic extract of freeze-dried, ground plant material | |
| leaf (BTO:0000713) | PubMed (21155593) | Combined methanolic extract of freeze-dried, ground plant material |
| Roles Classification |
|---|
| Biological Roles: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. |
| Application: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| robustaside E (CHEBI:70143) has role antimalarial (CHEBI:38068) |
| robustaside E (CHEBI:70143) has role metabolite (CHEBI:25212) |
| robustaside E (CHEBI:70143) is a enoate ester (CHEBI:51702) |
| robustaside E (CHEBI:70143) is a monosaccharide derivative (CHEBI:63367) |
| robustaside E (CHEBI:70143) is a phenols (CHEBI:33853) |
| robustaside E (CHEBI:70143) is a tertiary α-hydroxy ketone (CHEBI:139592) |
| robustaside E (CHEBI:70143) is a β-D-glucoside (CHEBI:22798) |
| IUPAC Name |
|---|
| 4-hydroxyphenyl 6-O-[(2E)-3-(1,4-dihydroxy-6-oxocyclohex-2-en-1-yl)prop-2-enoyl]-β-D-glucopyranoside |
| Registry Numbers | Sources |
|---|---|
| Reaxys:21220922 | Reaxys |
| Citations |
|---|